TOPK promotes immune suppression in kidney renal clear cell carcinoma and emerges as a prognostic and therapeutic target.

ABSTRACT:

SUBMITTER: Zheng Z 

PROVIDER: S-EPMC12359846 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature